Capricor Therapeutics | CAPR - Equity Capital And Reserves


Capricor Therapeutics reported $83.87M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Alterity Therapeutics Limited AUD 22.81M 5.29M Jun/2023
Bioline Rx USD 19.53M 537K Sep/2025
Capricor Therapeutics USD 83.87M 21.11M Sep/2025
Cipla INR 329.19B 16.3B Sep/2025
Cytokinetics USD -659.62M 138.5M Dec/2025
Geron USD 225.87M 22.83M Dec/2025
Grifols EUR 6.08B 34.72M Sep/2025
Immunic USD 10.5M 23.41M Sep/2025
J&J USD 78.47B 0 Sep/2025
Plus Therapeutics USD -1.35M 3.97M Dec/2023
Prothena USD 294.99M 29.34M Sep/2025
PTC Therapeutics USD -205.31M 49.56M Dec/2025
Sarepta Therapeutics USD 1.14B 179.5M Dec/2025